ADRA2A antibody (Adrenergic, alpha-2A-, Receptor) (C-Term)

Details for Product anti-ADRA2A Antibody No. ABIN2196819
Antigen
Epitope
C-Term
15
13
10
4
3
2
2
2
2
2
2
2
1
1
1
Reactivity
Human
90
56
54
4
4
4
4
3
2
2
1
1
1
1
Host
Rabbit
93
8
Clonality
Polyclonal
Conjugate
This ADRA2A antibody is un-conjugated
6
4
4
4
4
4
4
3
3
2
2
1
1
1
1
1
1
1
1
Application
Immunofluorescence (IF), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
49
31
25
22
14
13
7
7
4
3
1
Options
Immunogen Synthetic peptide corresponding to human ADRA2A at C-Terminal.
Isotype IgG
Cross-Reactivity Human, Mouse (Murine), Rat (Rattus)
Cross-Reactivity (Details) Calculated cross reactivity: Hu Mo Rt
Characteristics ADRA2A (Alpha-2A Adrenergic Receptor, Alpha-2A Adrenoreceptor, Alpha-2A Adrenoceptor, Alpha-2AAR, ADRA2R, ADRAR)
Purification Purified by immunoaffinity chromatography
Antigen
Alternative Name ADRA2A (ADRA2A Antibody Abstract)
Pathways EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Application Notes Optimal working conditions should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Buffer Supplied as a liquid in PBS, (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Storage Comment -20°C